In corso
A new sequencer for faster and more accurate genetic diagnoses
Condividi il progetto
Genetic neuromuscular and neurodegenerative diseases often involve long and complex diagnostic pathways. When diagnosis is delayed, the clinical process is affected: treatments may begin only after the disease has already progressed, making therapeutic decisions more difficult to guide. Reducing this waiting time means being able to identify the disease sooner, direct families more quickly toward appropriate therapeutic and care choices, and better support the patient throughout their care journey.
With this goal in mind, the Centro Dino Ferrari has launched a project to acquire a new state-of-the-art genetic sequencer, essential for obtaining faster and more reliable diagnostic confirmations, in line with the gold standard of genetic diagnostics. This instrument will be applicable to the genetic study of neuromuscular and neurodegenerative diseases with neonatal, pediatric, and adult onset, strengthening the Center’s diagnostic and research autonomy.
Methods and Technologies
The project involves the acquisition and use of a state-of-the-art genetic sequencer based on capillary electrophoresis, a well-established technology for the diagnostic confirmation of genetic variants identified through Next Generation Sequencing (NGS) approaches. Specifically, the sequencer will be used for:
-
rapid and reliable confirmation of genetic variants identified in patients
-
analysis of biological samples (blood, tissues, biopsies) from both pediatric and adult patients
-
family segregation studies, essential for clarifying the hereditary transmission of diseases
-
identification of complex mutations (deletions, duplications, expansions) that are not always detectable with standard approaches
Expected Impact
-
Achieve faster and more reliable genetic diagnoses to support clinical decision-making
-
Enable earlier initiation of therapies and improve patient management
-
Improve the accuracy of family studies, which are essential for genetic disorders
-
Support therapy monitoring and the identification of new genetic variants
-
Strengthen the diagnostic and research autonomy of the “Dino Ferrari Center”, reducing reliance on external services
Budget: €120,000
Laboratorio di riferimento
Laboratorio Cellule Staminali NeuraliGruppo Parkinson e disordini del movimento
Laboratorio di Biochimica e Genetica
Contatti e approfondimenti
Questo progetto è supportato da
